Influenza D-QIV vaccine (GSK)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza D-QIV vaccine (GSK), covering 2023-10-05 to 2023-10-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. [Phase 3]